Is Alzheimer’s Disease a Liver Disease of the Brain?
Open accessThe DOI matches its Crossref record; 130 of the 130 references it cites were found in a registry or an index.
Abstract
Clinical specialization is not only a force for progress, but it has also led to the fragmentation of medical knowledge. The focus of research in the field of Alzheimer's disease (AD) is neurobiology, while hepatologists focus on liver diseases and lipid specialists on atherosclerosis. This article on AD focuses on the role of the liver and lipid homeostasis in the development of AD. Amyloid-β (Aβ) deposits accumulate as plaques in the brain of an AD patient long before cognitive decline is evident. Aβ generation is a normal physiological process; the steady-state level of Aβ in the brain is determined by balance between Aβ production and its clearance. We present evidence suggesting that the liver is the origin of brain Aβ deposits and that it is involved in peripheral clearance of circulating Aβ in the blood. Hence the liver could be targeted to decrease Aβ production or increase peripheral clearance.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
![Fig.1 Some factors altering the balance between amyloid Aβ production and clearance leading to dyshomeostasis. Peripheral clearance can remove 40–50% of Aβ burden in the brain [25, 26]. Aβ, amyloid-β; AβPP, amyloid-β protein precursor, LRP1, low-density lipoprotein receptor-related peptide 1; LDLR, low-density-lipoprotein receptor; P-gp, P-glycoprotein.](https://figures.cochat.ai/paper-figures/06233310ef5d43cd8f768f053c5fa4bf/is-alzheimers-disease-a-liver-disease-of-the-brain-figure-1.jpg)
![Fig.2 Schematic representation of Alzheimer’s disease homeostasis showing amyloid-β (Aβ) production from amyloid-β protein precursor (AβPP) in the liver, dysregulated influx/efflux across blood-brain barrier (BBB) (1), transport in serum via soluble LRP1 (2) and exosomes [61] and saturable uptake of Aβ by liver via low-density lipoprotein receptor-related peptide 1 (LRP1) and low-density-lipoprotein receptor (LDLR) (3) with subsequent biliary clearance. RAGE, receptor for advanced glycation end products.](https://figures.cochat.ai/paper-figures/686adf0fd74c48389a6937bd7a50f794/is-alzheimers-disease-a-liver-disease-of-the-brain-figure-2.jpg)
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“However, this capacity decreases with age, which is partially attributed to the low expression of low-density lipoprotein receptor-related protein 1 (LRP-1) in hepatocytes.227–229”
From Antiageing strategy for neurodegenerative diseases: from mechanisms to clinical advances (2025) · cites this paper as [228]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The amyloid hypothesis of Alzheimer's disease at 25 years
Selkoe, D. J., & Hardy, J. (2016) · EMBO Molecular Medicine · doi:10.15252/emmm.201606210 · Cited by 6,164 · cited 1×
“typified by deposition of A within the brain [3, 4].”
BackgroundSleep Drives Metabolite Clearance from the Adult Brain
Xie, L., Kang, H., Xu, Q., Chen, M. J., Liao, Y., Thiyagarajan, M., O’Donnell, J., Christensen, D. J., Nicholson, C., Iliff, J. J., et al. (2013) · Science · doi:10.1126/science.1241224 · Cited by 5,411 · cited 1×
“Studies on sleep raise the possibility that altering sleep quality might impact A deposition and may also regulate the clearance of A from the brain [63].”
BackgroundQuerfurth, H. W., & LaFerla, F. M. (2010) · New England Journal of Medicine · doi:10.1056/nejmra0909142 · Cited by 4,569 · cited 1×
“typified by deposition of A within the brain [3, 4].”
BackgroundApolipoprotein E and Alzheimer disease: risk, mechanisms and therapy
Liu, C.-C., Kanekiyo, T., Xu, H., & Bu, G. (2013) · Nature Reviews Neurology · doi:10.1038/nrneurol.2012.263 · Cited by 3,459 · cited 1×
“A number of subsequent studies suggest that ApoE4 inhibits A clearance and/or is less efficient in mediating A peripheral clearance compared with ApoE3 and ApoE2 [47] (reviewed in [48, 49]).”
The antibody aducanumab reduces Aβ plaques in Alzheimer’s disease
Sevigny, J., Chiao, P., Bussière, T., Weinreb, P. H., Williams, L., Maier, M., Dunstan, R., Salloway, S., Chen, T., Ling, Y., et al. (2016) · Nature · doi:10.1038/nature19323 · Cited by 3,059
Alzheimer Disease Genetics Consortium (ADGC), Kunkle, B. W., The European Alzheimer’s Disease Initiative (EADI), Cohorts for Heart and Aging Research in Genomic Epidemiology Consortium (CHARGE), Genetic and Environmental Risk in AD/Defining Genetic, P. A. E. R. F. A. D. C. (., Grenier-Boley, B., Sims, R., Bis, J. C., Damotte, V., Naj, A. C., et al. (2019) · Nature Genetics · doi:10.1038/s41588-019-0358-2 · Cited by 2,946
Deaths: Leading Causes for 2017.
Heron, M. P. (2019) · PubMed · Cited by 2,108
Decreased Clearance of CNS β-Amyloid in Alzheimer’s Disease
Mawuenyega, K. G., Sigurdson, W., Ovod, V., Munsell, L., Kasten, T., Morris, J. C., Yarasheski, K. E., & Bateman, R. J. (2010) · Science · doi:10.1126/science.1197623 · Cited by 2,078
High performance plasma amyloid-β biomarkers for Alzheimer's disease
Nakamura, A., Kaneko, N., Villemagne, V. L., Kato, T., Doecke, J., Doré, V., Fowler, C., Li, Q.-X., Martins, R., Rowe, C., et al. (2018) · Nature · doi:10.1038/nature25456 · Cited by 1,681
RAGE mediates amyloid-β peptide transport across the blood-brain barrier and accumulation in brain
Deane, R., Du Yan, S., Submamaryan, R. K., LaRue, B., Jovanovic, S., Hogg, E., Welch, D., Manness, L., Lin, C., Yu, J., et al. (2003) · Nature Medicine · doi:10.1038/nm890 · Cited by 1,611 · cited 13×
“HCV may cross the BBB leading to neuroinflammation and neuropsychiatric symptoms [115].”
BackgroundInfluential
Cited by
Items 101–134 of 134
Du, Y., & Li, Z. (2024) · Translational Neuroscience · doi:10.1515/tnsci-2022-0357 · Cited by 1
“Brain A β deposits are reported to originate in the liver and the liver is involved in the clearance of circulating A β in the peripheral blood [18,19].”
Applicability of Vesicular Formulation in the Delivery of Hydrophobic Drugs
Chaudhari, G. (2025) · Asian Journal of Pharmaceutics · doi:10.22377/ajp.v19i01.6047 · Cited by 1
“[32]”
Proteomic Clusters Underlie Heterogeneity in Preclinical AD ProgressionPreprint
Wisch, J. K., Butt, O. H., Gordon, B. A., Schindler, S. E., Fagan, A. M., Yang, C., Boerwinkle, A. H., Benzinger, T. L. S., Holtzman, D. M., Morris, J. C., et al. (2022) · Research Square · doi:10.21203/rs.3.rs-1257861/v1 · Cited by 1
Finney, C. A., An, L., Winchester, L. M., Vogel, J., Wilkins, H. M., Burns, J. M., Swerdlow, R. H., Slawson, C. M., Rothstein, J. D., Lutz, M. W., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2025.12.09.693329 · Cited by 1
“This expansive footprint reinforces the view of AD as a multi-organ, multi-system disorder rather than a purely neurocentric pathology 59-61 .”
DIET INFLUENCES PERIPHERAL AMYLOID β METABOLISM: A ROLE FOR CIRCULATING INSULIN-LIKE GROWTH FACTOR IPreprint
Herrero-Labrador, R., Trueba-Sáiz, Á., Martinez‐Rachadell, L., de Sevilla, E. F., Díaz-Pacheco, S., Fernandez, A. F., & Aleman, I. T. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.07.09.180265
“Thus, the relationship between peripheral and central Aβ is still under debate (42); indeed, a substantial part of brain Aβ”
BackgroundAssociation of Hearing Loss With Cognitive Decline in Alzheimer’s Disease and Vascular DementiaPreprint
Liu, B., Zhao, Y., Zhao, G., Jin, L., & Li, W. (2021) · Research Square · doi:10.21203/rs.3.rs-1075876/v1
Ghaffar, A. (2022) · Queensland University of Technology · doi:10.5204/thesis.eprints.236251
Wei, J., Hu, L., Xu, S., Li, Y., Liao, F., Zhang, X., Fang, X., Ding, L., Wang, T., Chen, Z., et al. (2022) · Research Square · doi:10.21203/rs.3.rs-2348942/v1
Wang, B., Lu, D., Zhang, C., Xu, N., Qiu, S., Bai, Y., Hu, B., & Qin, Z. S. (2022) · IEEE International Conference on Bioinformatics and Biomedicine (BIBM) · doi:10.1109/bibm55620.2022.9995232
“suggested that brain Aβ deposits originate from the liver, which contributes to the removal of circulating plasma Aβ [22].”
BackgroundKharibegashvili, A. (2022) · International Journal of Psychiatry Research · doi:10.33545/26648962.2022.v4.i1a.36
M’Bra, P. E. H., Hamilton, L. K., Moquin‐Beaudry, G., Aubin, M., Mangahas, C. L., Pratesi, F., Brunet‐Ratnasingham, E., Castonguay, A., Mailloux, S., Galoppin, M., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.09.04.610637
Li, T., Yi, J., Hu, X., Wu, H., Wang, K., & Zhou, B. (2024) · Journal of Alzheimer s Disease Reports · doi:10.1177/25424823241299661
“The effects of individual dementia SNPs on CHC are displayed through the scatter plots(Figure2)andforestplots(Figure3),withcorresponding leave-one-out analysis in Supplemental Figures 13 and14.”
InfluentialGürkan, G., Akdag, B., Erdoğan, M. A., & Erbaş, O. (2025) · Journal of Korean Neurosurgical Society · doi:10.3340/jkns.2025.0110
“Although brain β-amyloid may also originate from peripheral sources such as the liver 3) , imatinib’s longer plasma half-life compared with nilotinib 44,58) may allow more sustained peripheral action, reducing amyloid before it enters the CNS 7) .”
Interactions with polygenic background impact quantitative traits in the UK BiobankPreprint
Ferreira, L. A. F., Hu, S., Davies, R. W., & Myers, S. R. (2025) · medRxiv · doi:10.1101/2025.11.14.25340263
“Comparing with”
Cleary, J. A. (2024) · WakeSpace Scholarship (Wake Forest University)
Liver Integrity Over the Adult Lifespan and Risk of Alzheimer’s Disease and Related Dementias
Lu, Y. (2023) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/gfb0-bp75
Jeong, S. (2026) · Gut and Liver · doi:10.5009/gnl250606
“10 Taken together, these observations support the idea that hepatic metabolic dysfunction and liver-derived signaling can propagate harmful signals to the brain through chronic inflammation, disturbed metabolic networks, and impaired β -amyloid handling, thereby contributing to the initiation or…”
Vatashchuk, M., Hurza, V., Pan, K., Bayliak, M. M., Gospodaryov, D. V., Lushchak, V. I., & Garaschuk, O. (2026) · Antioxidants · doi:10.3390/antiox15020191
“Recent cumulative evidence refutes the purely central-nervous-system-centered etiology of AD and positions it as a metabolic disease of the entire body [9,10,43–45].”
Marina-Latorre, M., Lobo, L., Artime, E., & Pereiro, R. (2026) · Spectrochimica Acta Part B Atomic Spectroscopy · doi:10.1016/j.sab.2026.107466
Xiong, X., Yang, G., Yao, Y., & Lin, C. (2026) · Medicine · doi:10.1097/md.0000000000047976
“Such studies indicate that the interactions between the gut and liver can have a certain degree of impact on the brain function, leading to conditions like hepatic encephalopathy, Alzheimer’s disease, [15] Parkinson’s disease, [16] anxiety, [17] depression.”
COVID-19 and neurodegeneration: Perspectives on the impact of viruses on the brain
Luna-Tenorio, E., Torres-Mendoza, J. N., Franco-Colín, M., Álvarez‐González, I., de la Cruz‐López, F., Garcés‐Ramírez, L., & Luna‐Muñoz, J. (2026) · Journal of Alzheimer s Disease · doi:10.1177/13872877261434258
Faraci, G., Goodfriend, B., Bishop, J., Vu, M., Avelar‐Barragan, J., Dunham, S. J. B., Rothman, J. A., Whiteson, K., Cheema, A. K., Milinkeviciute, G., et al. (2026) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2026.04.007
“Notably, emerging evidence implicates liver dysfunction in the pathogenesis of AD as part of a liver-plasma-brain axis, in which impaired hepatic clearance of circulating A β contributes to disease pathology (Bassendine et al., 2020; Estrada et al., 2019).”
Jiang, Q., & Yan-Jiang, W. A. N. G. (2026) · Shengming kexue · doi:10.3724/cbls.2026100
El-Mezayen, N. S., Eesa, Y. A., Hassan, W. A., Aly, D. A., Saafan, Y. S., Khedr, E. M., Sherief, A., & Elkordy, E. A. (2026) · Scientific Reports · doi:10.1038/s41598-026-55386-z
“In addition, liver function parameters and fibrosis-related changes have been associated with circulating AD biomarkers 83 , Zhang 84, supporting the concept of a liver–brain axis in AD 85 .”
Hey, J. A., Geerts, H., Schaefer, J. F., Short, S. M., van der Graaf, P. H., Abushakra, S. R., Power, A., Tolar, M., & Yu, Y. (2026) · Research Square · doi:10.21203/rs.3.rs-10570608/v1
He, S., Han, X., Chen, J., Li, C., Li, J., Zhou, Y., Mao, W., Zhang, X., Chen, Y., Zhan, J., et al. (2026) · Metabolic Brain Disease · doi:10.1007/s11011-026-01959-w
“…IR disrupt hepatic homeostasis, suppressing these clearance pathways and cre - ating a “peripheral reservoir” dysfunction that may elevate plasma Aβ levels, potentially overwhelming central clear - ance mechanisms across the blood-brain barrier (BBB) (Verma et al. 2023 ; Bassendine et al. 2020 ).”
Ramashetty, R., Naaz, R., M., R. C., Madhunapantula, S. V., & Uthaiah, C. A. (2026) · Nutrients · doi:10.3390/nu18182942
“Furthermore, experimental evidence indicates that vitamin D may facilitate amyloid clearance through the blood–brain barrier [23,24].”
Tianci, M., Yongyi, L., Ding, Y., Liu, S., Gao, C., Li, X., Tong, Z., & Yan, L. (2026) · Frontiers in Aging · doi:10.3389/fragi.2026.1921485
“…that address inflammation, oxidative stress, autophagy, A β clearance, transport functions, and neuronal survival better align with AD’s systemic pathology and hold greater clinical promise (Bassendine et al., 2020; Sagare et al., 2012; Li et al., 2018; Liu et al., 2024; Alsubaie et al., 2022).”
OXIDATIVE STRESS AND MORPHOLOGICAL CHANGES IN THE BRAIN ON A HIGH-FAT DIET
Иноятова, Ф. Х., Abdullayeva, M. I., & Mirakhmedova, K. G. (2025) · Central Asian Journal of Medicine
NEURODEGENERATION AS A COMPLICATION OF NONALCOHOLIC FATTY LIVER DISEASE (Review article)
Иноятова, Ф. Х., & Abdullayeva, M. I. (2023) · Central Asian Journal of Medicine
Lam, S., Arif, M., Song, X., Uhlén, M., & Mardinoglu, A. (2022) · doi:10.3389/fnmol.2022.889728.s006
Zhang, Y., Guo, K., Zhang, P., Zhang, M., Li, X., Zhou, S., Sun, H., Wang, W., Wang, H., & Hu, Y. (2022) · doi:10.3389/fgene.2022.942203.s001
Yang, H., Liao, Z., Zhou, Y., Gao, Z., & Mao, Y. (2024) · doi:10.3389/fpubh.2024.1375379.s001
Metadata
- Authors
- Bassendine, M. F., Taylor-Robinson, S. D., Fertleman, M., Khan, M., & Neely, D.
- Affiliations
- Imperial College London (GB)
- University Hospitals Coventry and Warwickshire NHS Trust (GB)
- Newcastle upon Tyne Hospitals NHS Foundation Trust (GB)
- Corresponding author
- Bassendine, Margaret F.
- Venue
- Journal of Alzheimer's Disease
- Publisher
- SAGE Publications
- Published
- 2020-05-05
- Volume
- 75
- Issue
- 1
- Pages
- 1-14
- ISSN
- 1387-2877 (ISSN-L)
- 1875-8908
- PMC
- PMC7306895
- OpenAlex
- W3014127696
- Cited by
- 124
- References
- 129
- Citations by year
- 2026: 16 · 2025: 30 · 2024: 24 · 2023: 18 · 2022: 25 · 2021: 8 · 2020: 3
- FWCI
- 1.72
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Journal of Alzheimer s Disease (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Spiral (Imperial College London) (submittedVersion, cc-by-nc)
- Funders
- NIHR Biomedical Research Centre, Royal Marsden NHS Foundation Trust/Institute of Cancer Research
- National Institute for Health and Care Research (2011-NIHR 7068)
- Imperial College London
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- Alzheimer's disease, liver
- MeSH terms
- Alzheimer Disease, Animals, Brain, Humans, Liver, Amyloid beta-Peptides, Amyloid beta-Protein Precursor, Metabolic Syndrome, Lipid Metabolism
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.